CytomX Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $201.8M
Liabilities Breakdown FY2023
Total Liabilities: $249.2M
Asset Breakdown
Total Assets: $201.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.2M | 8.5% |
| Accounts Receivable | $3.4M | 1.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.0M | 2.0% |
| Goodwill | $949.0K | 0.5% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $176.3M | 87.4% |
Liabilities Breakdown
Total Liabilities: $249.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.5M | 0.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $247.8M | 99.4% |